Epista Life Science A/S — Credit Rating and Financial Key Figures

Epista Life Science A/S (CVR number: 32141064) is a company from HØRSHOLM. The company recorded a gross profit of 79.7 mDKK in 2023. The operating profit was 9628 kDKK, while net earnings were 10.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was 19.7 %, which can be considered excellent and Return on Equity (ROE) was 31.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 48.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Epista Life Science A/S's liquidity measured by quick ratio was 1.1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.